Inge H Briaire-de Bruijn Selected Research

Ovarian Neoplasms (Ovarian Cancer)

1/2020

Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Inge H Briaire-de Bruijn Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 12/2004
8	Chondrosarcoma 01/2023 - 08/2009
3	Myxoid Liposarcoma 01/2020 - 04/2015
2	Chondroma (Enchondroma) 11/2020 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2009
2	Glioma (Gliomas) 12/2019 - 05/2015
2	Leiomyosarcoma 01/2019 - 01/2018
2	Synovial Sarcoma (Synovioma) 01/2019 - 04/2015
2	Osteosarcoma (Osteogenic Sarcoma) 01/2017 - 05/2013
1	Chordoma 01/2024
1	Giant Cell Tumors (Giant Cell Tumor) 09/2022
1	Bone Cysts (Bone Cyst) 12/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Cholangiocarcinoma 01/2020
1	Leukemia 12/2019
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Osteoblastoma 01/2017
1	Mesenchymal Chondrosarcoma 10/2016
1	Smooth Muscle Tumor 11/2015
1	Pheochromocytoma 11/2015
1	Paraganglioma (Paragangliomas) 11/2015
1	Esophageal Squamous Cell Carcinoma 04/2015
1	Testicular Neoplasms (Testicular Cancer) 04/2015
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2010
1	Myxoma (Myxomas) 07/2009
1	Fibroma (Fibromatosis) 01/2006
1	Enchondromatosis (Ollier Disease) 12/2004

Drug/Important Bio-Agent (IBA)

5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 05/2015
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2017
2	talazoparibIBA 01/2023 - 12/2019
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023 - 12/2019
2	AlginatesIBA 01/2023 - 01/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 12/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 12/2019
2	Histone Deacetylase InhibitorsIBA 09/2022 - 01/2019
2	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2017
2	alpha-hydroxyglutarateIBA 11/2020 - 12/2019
2	Polysaccharides (Glycans)IBA 01/2020 - 01/2016
2	ParaffinIBA 01/2017 - 12/2015
2	histone H3 trimethyl Lys4IBA 01/2017 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 11/2015
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2017 - 11/2015
2	Formaldehyde (Formol)FDA Link 01/2017 - 12/2015
2	Fumarate Hydratase (Fumarase)IBA 01/2017 - 11/2015
2	5-hydroxymethylcytosineIBA 01/2017 - 11/2015
2	Messenger RNA (mRNA)IBA 05/2013 - 07/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2021
1	A-Form DNA (A-DNA)IBA 11/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2020
1	Small Interfering RNA (siRNA)IBA 11/2020
1	sapanisertibIBA 01/2020
1	Mannose (D-Mannose)IBA 01/2020
1	MethyltransferasesIBA 12/2019
1	AGI-5198IBA 01/2019
1	SurvivinIBA 01/2019
1	Macrophage Colony-Stimulating FactorIBA 01/2018
1	ChromatinIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	ABT-737IBA 10/2016
1	Histones (Histone)IBA 11/2015
1	Tricarboxylic AcidsIBA 11/2015
1	EnzymesIBA 11/2015
1	AntigensIBA 04/2015
1	Somatomedin Receptors (Somatomedin Receptor)IBA 05/2013
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 05/2013
1	Tyrosine Kinase InhibitorsIBA 08/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2009
1	Imatinib Mesylate (Gleevec)FDA Link 08/2009
1	Dasatinib (BMS 354825)FDA Link 08/2009
1	Peptides (Polypeptides)IBA 08/2009
1	Phosphotransferases (Kinase)IBA 08/2009
1	DecorinIBA 07/2009
1	CollagenIBA 07/2009
1	Proteins (Proteins, Gene)FDA Link 07/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2006
1	OligonucleotidesIBA 12/2004
1	Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA 12/2004

Therapy/Procedure

5	Radiotherapy 01/2023 - 08/2009
3	Immunotherapy 01/2024 - 04/2015
3	Drug Therapy (Chemotherapy) 01/2023 - 08/2009
2	Therapeutics 01/2020 - 01/2019
1	Duration of Therapy 01/2023
1	Lasers (Laser) 01/2020